Hepatitis C virus with normal transaminase levels

Digestive Diseases

Volumn 25, Issue 3, 2007, Pages 277-278

  Puoti, Claudio ^a  

^a Marino Hospital Rome   (Italy)

Author keywords

'Healthy' carriers; HCV; Interferon; Normal alanine aminotransferase levels

Indexed keywords

ALANINE AMINOTRANSFERASE; PEGINTERFERON ALPHA2A; RIBAVIRIN; ALPHA2A INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2A; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ANTIVIRAL THERAPY; CHRONIC HEPATITIS; CLINICAL DECISION MAKING; CONFERENCE PAPER; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; ARTICLE; BLOOD; ENZYMOLOGY;

ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; POLYETHYLENE GLYCOLS; RIBAVIRIN;

EID: 35448949575     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103901     Document Type: Conference Paper

References (21)

1. Marcellin P, Lévy S, Erlinger S: Therapy of hepatitis C: patients with normal aminotransferase levels. Hepatology 1997;26(suppl 1):133S-136S.
2. Puoti C, Castellacci R, Montagnese F: Hepatitis C virus carriers with normal aminotransferase levels: Healthy people or true patients? Digest Liver Dis 2000;32:634-643.
3. Puoti C, Magrini A, Stati T, Rigato P, Montagnese F, Rossi P, et al: Clinical, histological and virological features of hepatitis C virus carriers with persistently normal aminotransferase levels. Hepatology 1997;26:1393-1398.
4. Alberti A, Morsica G, Chemello L, Cavalletto D, Noventa F, Pontisso P, et al: Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992;340:697-698.
5. Martinot-Peignoux M, Boyer N, Cazals-Hatem D, Bach-Nga P, Gervais A, Le Breton A, et al: Perspective study of anti-hepatitis C virus-positive patients with persistently normal serum ALT with or without detectable serum HCV RNA. Hepatology 2001;34:1000-1005.
6. Persico M, Persico E, Suozzo R, Conte S, De Seta M, Sasso FC, et al: Natural history of hepatitis C virus carriers with persistently normal transaminase levels. Gastroenterology 2000;118:760-764.
7. Cividini A, Rebucci C, Silini E, Mondelli MU: Is the natural history of HCV carriers with normal aminotransferase levels really benign? Gastroenterology 2001;121:1526-1527.
8. Mathurin P, Moussali J, Cadranel JF, Thibault V, Charlotte F, Dumouchel P, et al: Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology 1998;27:868-872.
9. Puoti C, Guido M, Mangia A, Persico M, Prati D: Italian Study for the Study of the Liver (AISF) Ad Hoc Committee 'HCV carriers with persistently normal ALT levels'. Position paper. DLD 2003;35:362-369.
10. Puoti C, Castellacci R, Montagnese F, Zaltron S, Stornaiuolo GF, Bergami N, et al: Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: The Italian Prospective Study of the Asymptomatic C Carriers (ISACC). J Hepatol 2002;37:117-123.
11. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al: Updated definitions of healthy ranges for serum alanine aminotransferase. Ann Intern Med 2002;137:1-10.
12. Puoti C, Stati T, Magrini A: Serum HCV RNA titer does not predict the severity of liver damage in HCV carriers with normal aminotransferase levels. Liver 1999;19:104-109.
13. Pradat P, Alberti A, Poynard T, Esteban JI, Weiland O, Marcellin P, et al: Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European Collaborative Study. Hepatology 2002;36:973-977.
14. Hui CK, Belaye T, Montegrande K, Wright TL: A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase. J Hepatol 2003;38:511-517.
15. Puoti C, Bellis L, Martellino F, Durola L, Galossi A, Guarisco R, et al: HCV carriers with 'normal' ALT levels: treat the disease, not the test. J Hepatol 2005;43:534-535.
16. Puoti C, Bellis L, Martellino F, Spilabotti L, Galossi A, Durola L, et al: Occurrence of HCC in a apparently 'healthy' HCV carrier. Eur J Gastroenterol Hepatol 2005;17:1263-1264.
17. Rumi MG, De Filippi F, Donato MF, Del Ninno E, Colombo M: Progressive hepatic fibrosis in healthy carriers of hepatitis C virus with a transaminase breakthrough. J Viral Hepatitis 2002;9:71-74.
18. Tassopoulos NC: Treatment in patients with normal ALT levels. J Hepatol 1999;31(suppl 1):193-196.
19. Bacon BR: Treatment of patients with hepatitis C and normal serum aminotransferase levels. Hepatology 2002;36(suppl 1):S179-S184.
20. 2a (40 kDa) and ribavirin. Gastroenterology 2004;127:1724-1732.
21. Alberti A: Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanine aminotransferase levels. J Hepatol 2005;42:266-274.